title: Effect of eptifibatide on coronary flow reserve following coronary stent implantation (an ESPRIT substudy). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy.
authors.affiliation: Cardiovascular Division, Department of Medicine, the University of California San Francisco, San Francisco, California 94118, USA. mgibson@perfuse.org
authors.forename: C M
authors.initials: CM
authors.lastname: Gibson
authors.forename: D J
authors.initials: DJ
authors.lastname: Cohen
authors.forename: E A
authors.initials: EA
authors.lastname: Cohen
authors.forename: H K
authors.initials: HK
authors.lastname: Lui
authors.forename: S A
authors.initials: SA
authors.lastname: Murphy
authors.forename: S J
authors.initials: SJ
authors.lastname: Marble
authors.forename: M
authors.initials: M
authors.lastname: Kitt
authors.forename: T
authors.initials: T
authors.lastname: Lorenz
authors.forename: J E
authors.initials: JE
authors.lastname: Tcheng
mesh_terms: D000328:Adult; D000368:Aged; D015901:Angiography, Digital Subtraction; D015906:Angioplasty, Balloon, Coronary; D017023:Coronary Angiography; D003326:Coronary Circulation / Q000187:drug effects*; D003327:Coronary Disease / Q000000981:diagnostic imaging / Q000188:drug therapy*; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D000077542:Eptifibatide; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000008:administration & dosage* / Q000009:adverse effects; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D015607:Stents
chemical_list: D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D000077542:Eptifibatide